MAP2K1 and neoplasm: In contrast, other studies have found that MEK1/2 inhibition selectively eliminated M2‐type macrophages using a model system which had sparse M1‐type macrophages and tumour cells that underwent immunogenic cell death due to MEK1/2 inhibition (Baumann et al., 2021).